HPV vaccine recommendations

Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary P. Glode, Mary Anne Jackson, Harry L. Keyserling, Yvonne A. Maldonado, Dennis L. Murray, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis

Research output: Contribution to journalReview articlepeer-review

90 Scopus citations


On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.

Original languageEnglish (US)
Pages (from-to)602-605
Number of pages4
Issue number3
StatePublished - Mar 2012


  • Adolescents
  • Cancer
  • Females
  • HPV
  • Human papillomavirus
  • Immunization
  • Males
  • Vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'HPV vaccine recommendations'. Together they form a unique fingerprint.

Cite this